Biohit Oyj 16.10.2018 12:20 local time
Stina Syrjänen resigns from Biohit Oyj’s Board of Directors
Stina Syrjänen has notified Biohit Oyj that she will resign from the company’s Board of Directors. The resignation is effective immediately.
The Board of Directors of Biohit Oyj will continue to operate with five members as a new member was elected at the Extraordinary Shareholders' Meeting on the 16th of August 2018.
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
Biohit Oyj in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com